The gut mucosa disruption is a hallmark of inflammatory bowel diseases (IBD) characterized by an upregulated NLRP3 inflammasome pathway, which can be triggered following short chain fatty acids (SCFAs) binding to GPR43 of the enterocytes (19, 22, 32, 34). Here, NLRP3 is linked to inflammatory bowel disease.